Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of pharmaceuticals and agrochemicals. Its boronate ester group enables efficient carbon-carbon bond formation, particularly in the development of fluorinated heterocyclic compounds. The presence of the fluoroethyl moiety allows for enhanced metabolic stability and bioavailability in drug candidates. Commonly employed in medicinal chemistry for constructing pyrazole-based scaffolds found in bioactive molecules and potential therapeutic agents.